Browse Studies — Arctuva

Phase 2

Effects of Treatments on the Microbiome in Healthy Volunteers and Patients With Atopic Dermatitis

Background: \- Atopic dermatitis, or eczema, is a chronic skin disorder. Patients sometimes have infections with S. aureus bacteria. Researchers want to study…

EczemaDermatitisSkin Diseases, Genetic+2 more

Estimated

~$10 – $5,625

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)NCT01631617

Phase 2

A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

This is a phase 2b, multicenter, randomized, double-blind, placebo-controlled study.

Atopic DermatitisAtopicDermatitis+5 more

Estimated

~$10 – $8,750

Apollo Therapeutics LtdNCT07599813

A Prospective, Multi-center Observational Study Characterizing Clinical Outcomes of Patients Receiving Abrocitinib for Moderate-to-severe Atopic Dermatitis Who Had an Inadequate Response (or Intolerance) to ≤2 Previous Biologic Therapies Approved for Moderate-to-severe Atopic Dermatitis

This is a prospective, multi-center observational study characterizing clinical and patient reported outcomes of patients receiving abrocitinib for moderate-to…

Atopic DermatitisAtopic Dermatitis, UnspecifiedDermatitis, Atopic

Estimated

~$10 – $1,125

PfizerNCT06899204

Observational

Efficacy of 3% Kanuka Oil Versus 1% Hydrocortisone Cream in the Treatment of Patients With Mild Atopic Dermatitis

Atopic dermatitis is a common disease affecting millions worldwide. A common associated symptom in this population is pruritus. We seek to investigate the use …

Dermatitis, AtopicPruritus

Estimated

~$10 – $8,750

Nexgen Dermatologics, Inc.NCT06488742